Has John Rahhal, MD received payments from drug or device companies?

Yes. Drug and device makers reported $696 in general payments to John Rahhal, MD across 40 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Rahhal, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Rahhal, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Rahhal, MD

Psychiatry · Oklahoma City, OKNPI 1164490223

Payments from drug & device makers

$696in general payments, 2019–2025

Across 40 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$222
Teva Pharmaceuticals USA, Inc.$95
Johnson & Johnson$57
Axsome Therapeutics, Inc.$45
Noven Therapeutics, LLC$38
Otsuka America Pharmaceutical, Inc.$33
plus $206 from 10 others

What the payments were for

Food & beverage$696100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	13	$222
Teva Pharmaceuticals USA, Inc.	6	$95
Johnson & Johnson	3	$57
Axsome Therapeutics, Inc.	3	$45
Noven Therapeutics, LLC	2	$38
Otsuka America Pharmaceutical, Inc.	2	$33
Neurocrine Biosciences, Inc.	2	$28
Alkermes, Inc.	1	$25
Sage Therapeutics, LLC	1	$25
Collegium Pharmaceutical, Inc.	1	$23
Supernus Pharmaceuticals, Inc.	1	$20
Tris Pharma Inc	1	$19
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$18
Idorsia Pharmaceuticals US Inc	1	$16
Indivior Inc.	1	$14

How this compares

$696 in reported general payments places this provider in the 65th percentile of 328 psychiatry providers in Oklahoma.

See all psychiatry providers in Oklahoma →

Medicare billing

Part B allowed, 2024

$136,589

Medicare patients

195

Services billed

1,433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Bupropion XlBupropion Hcl	133	$7,090
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine	89	$7,084
Duloxetine Hcl	148	$4,012
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	87	$3,135
Ziprasidone Hcl	20	$1,918
Vilazodone Hcl	16	$1,133
Lamotrigine	114	$1,083
Alprazolam	186	$956
Trazodone Hcl	105	$942
Sertraline Hcl	87	$854
Escitalopram Oxalate	65	$830
Hydroxyzine Pamoate	37	$818
Aripiprazole	22	$738
Methylphenidate Hcl	26	$716
Clonazepam	95	$705

Paid to pharmacies, not to this prescriber.

Other psychiatry in Oklahoma City

Louise ThurmanOklahoma City$6.2M
Veronique SebastianOklahoma City$3.8M
Marvin PeytonOklahoma City$3.2M
Willis HollowayOklahoma City$1.4M
Courtney NixonOklahoma City$1.2M
Surinder RandhawaOklahoma City$142K
Adonis Al BotrosOklahoma City$73K
Josephine DeguzmanOklahoma City$38K
Haisam Al KhouriOklahoma City$10K
Patrick HornOklahoma City$8K

See the full list for Oklahoma →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →